Unlock all Features See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson

Last Updated: January 25, 2022

DrugPatentWatch Database Preview

Litigation Details for BlackBerry Limited v. Facebook, Inc. (C.D. Cal. 2018)

Email this page to a colleague

« Back to Dashboard

BlackBerry Limited v. Facebook, Inc. (C.D. Cal. 2018)

Docket ⤷  Try it Free Date Filed 2018-03-05
Court District Court, C.D. California Date Terminated 2021-02-15
Cause 35:271 Patent Infringement Assigned To George H. Wu
Jury Demand Plaintiff Referred To Karen L. Stevenson
Patents 10,610,649; 8,105,768; 8,658,774; 9,010,165
Attorneys Andrew M Legolvan; Andrew Mace; Chad J Peterman; Daryl Stuart Bartow; David M Beckwith; David T Okano; Dawn M David; Dena Chen; Edward R McGah , Jr; Elizabeth Lee Stameshkin; Heidi Lyn Keefe; Iman Lordgooei; James R Asperger; Jeffrey William Nardinelli; Jordan R Jaffe; Keith M Cochran; Kenneth M Fitzgerald; Kevin P B Johnson; Kristen Bird; Lowell D Mead; Mark R Weinstein; Matthew J Brigham; Michael G Rhodes; Miles D Freeman; Patrick Schmidt; Phillip E Morton; Pushkal Mishra; Randall R Lee; Ray R Zado; Scott L Watson; Yar R Chaikovsky; Zachary Christian Flood
Firms Blackberry Carporation, Vice President Deputy General Counsel; Cooley LLP; Duane Morris LLP; Fitzgerald Knaier; Paul Hastings LLP; Quinn Emanuel Urquhart & Sullivan LLP; Quinn Emanuel Urquhart and Sullivan LLP; Quinn Emanuel Urquhart Oliver & Hedges LLP; Quinn Emanuel Urquhart Oliver and Hedges
Link to Docket External link to docket
Biologic Drugs cited in BlackBerry Limited v. Facebook, Inc.

The biologic drugs covered by the patents cited in this case are ⤷  Try it Free , ⤷  Try it Free , ⤷  Try it Free , ⤷  Try it Free , and ⤷  Try it Free .

Details for BlackBerry Limited v. Facebook, Inc. (C.D. Cal. 2018)

Date Filed Document No. Description Snippet Link To Document
2018-04-04 15 5 6 7 8 9 10 165. The ’173 Patent thus describes, inter alia, “[a]… BlackBerry’s Patents 14 46. U.S. Patent No. 7,372,961 (“’961 Patent”) is entitled “Method…features covered by the 8 Patents-in-Suit. 9 5. The Patents-in-Suit cover, for example:…seeking patent protection, and as detailed below, BlackBerry owns rights to an array 10 of patented technologies…(collectively, the “Patents-in-Suit”). Defendants infringe the BlackBerry Patents-in- 14 Suit by using External link to document
2020-04-06 661 Brief (non-motion non-appeal) premised on statements made in Patent Owner IPR Response); accord 10 Duncan Parking Techs., Inc. v.…AG v. 28 ThyssenKrupp Elevator Americas Corp., 649 F.3d 1350, 1357 (“It is proper to consult …reinforce the structural meaning of the terms. Inventio, 649 F.3d at 1359. 6 Finally, BlackBerry …Products, Inc. v. Rosen Entertainment Systems, L.P., 610 Fed. Appx. 968, 972 (Fed. 3 Cir. 2015). This …networks. ’236 Patent at 3:7- 22 9. There is not a single embodiment disclosed in the ’236 Patent that does External link to document
2020-04-23 664 Brief (non-motion non-appeal) 3 for summary judgment that U.S. Patent 8,429,236 (the “’236 Patent”) is invalid under 4 35 U.S.C…proceedings have made clear that the ’236 Patent 8 is patent-eligible, and that Defendants’ Motion should… ) THAT U.S. PATENT NO. 22 corporation, WHATSAPP INC., a ) 8,429,236 IS INVALID…entirety,1 the claims of the ’236 Patent do, in fact, result in a 8 technological improvement to the… summary judgment at step two. 8 As the moving party and patent challenger, it is Defendants’ burden External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.